Cargando…

Characteristics of CD4+CD25+ regulatory T cells in the peripheral circulation of patients with head and neck cancer

Patients with squamous cell carcinoma of the head and neck (SCCHN) have depressed antitumour immunity. The presence of CD4+CD25+ (T(reg)) cells in these patients might be, in part, responsible for downregulation of antitumour immune responses. To evaluate the frequency and characteristics of T(reg)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schaefer, C, Kim, G G, Albers, A, Hoermann, K, Myers, E N, Whiteside, T L
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2005
Materias:	Molecular Diagnostics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361917/ https://www.ncbi.nlm.nih.gov/pubmed/15714205 http://dx.doi.org/10.1038/sj.bjc.6602407

Ejemplares similares

Intratumoral regulatory T cells upregulate immunosuppressive molecules in head and neck cancer patients
por: Jie, H-B, et al.
Publicado: (2013)

Circulating microRNAs as prognostic therapy biomarkers in head and neck cancer patients
por: Summerer, I, et al.
Publicado: (2015)

Prolactin receptor is a negative prognostic factor in patients with squamous cell carcinoma of the head and neck
por: Bauernhofer, T, et al.
Publicado: (2011)

Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer
por: Lugli, A, et al.
Publicado: (2010)

Diagnosis of head-and-neck cancer from exhaled breath
por: Hakim, M, et al.
Publicado: (2011)

Levels of circulating CD45(dim)CD34(+)VEGFR2(+) progenitor cells correlate with outcome in metastatic renal cell carcinoma patients treated with tyrosine kinase inhibitors
por: Farace, F, et al.
Publicado: (2011)

Expression of endoglin (CD105) in cervical cancer
por: Zijlmans, H J, et al.
Publicado: (2009)

Microsatellite mutations in buccal cells are associated with aging and head and neck carcinoma
por: Slebos, R J C, et al.
Publicado: (2008)

Serum antibodies to the HPV16 proteome as biomarkers for head and neck cancer
por: Anderson, K S, et al.
Publicado: (2011)

Low density of CD3+, CD4+ and CD8+ cells is associated with increased risk of relapse in squamous cell cervical cancer
por: Nedergaard, B S, et al.
Publicado: (2007)

Mitochondrial DNA mutations in head and neck cancer are infrequent and lack prognostic utility
por: Challen, C, et al.
Publicado: (2011)

Effector CD8(+)CD45RO(−)CD27(−)T cells have signalling defects in patients with squamous cell carcinoma of the head and neck
por: Kuss, I, et al.
Publicado: (2003)

Tumour-infiltrating CD4(+) and CD8(+) lymphocytes as predictors of clinical outcome in glioma
por: Han, S, et al.
Publicado: (2014)

Cytoglobin is upregulated by tumour hypoxia and silenced by promoter hypermethylation in head and neck cancer
por: Shaw, R J, et al.
Publicado: (2009)

Definitive chemoradiation alters the immunologic landscape and immune checkpoints in head and neck cancer
por: Sridharan, Vishwajith, et al.
Publicado: (2016)

Detection of circulating tumour cells in peripheral blood with an automated scanning fluorescence microscope
por: Ntouroupi, T G, et al.
Publicado: (2008)

The utility of molecular diagnostics to predict recurrence of head and neck carcinoma
por: Pena Murillo, C, et al.
Publicado: (2012)

Impact of p16 status on pro- and anti-angiogenesis factors in head and neck cancers
por: Baruah, P, et al.
Publicado: (2015)

Circulating tumour cells in the central and the peripheral venous compartment in patients with metastatic breast cancer
por: Peeters, D J E, et al.
Publicado: (2011)

Clinical value of circulating endothelial cells and of soluble CD146 levels in patients undergoing surgery for non-small cell lung cancer
por: Ilie, M, et al.
Publicado: (2014)

Clinicopathological significance of mitochondrial D-Loop mutations in head and neck carcinoma
por: Lièvre, A, et al.
Publicado: (2006)

Restoration of caveolin-1 expression suppresses growth and metastasis of head and neck squamous cell carcinoma
por: Zhang, H, et al.
Publicado: (2008)

Tumour-infiltrating CD68+ and CD57+ cells predict patient outcome in stage II–III colorectal cancer
por: Chaput, N, et al.
Publicado: (2013)

Tumour-infiltrating lymphocytes predict response to definitive chemoradiotherapy in head and neck cancer
por: Balermpas, P, et al.
Publicado: (2014)

Endothelial CD276 (B7-H3) expression is increased in human malignancies and distinguishes between normal and tumour-derived circulating endothelial cells
por: Kraan, J, et al.
Publicado: (2014)

The phosphatase and tensin homologue deleted on chromosome 10 mediates radiosensitivity in head and neck cancer
por: Pattje, W J, et al.
Publicado: (2010)

Identification of chemoresistant factors by protein expression analysis with iTRAQ for head and neck carcinoma
por: Nishimura, K, et al.
Publicado: (2014)

Downregulation of EGFR in hypoxic, diffusion-limited areas of squamous cell carcinomas of the head and neck
por: Mayer, Arnulf, et al.
Publicado: (2016)

Rapid nodal staging of head and neck cancer surgical specimens with flow cytometric analysis
por: Häyry, Valtteri, et al.
Publicado: (2018)

Concurrent infiltration by CD8(+) T cells and CD4(+) T cells is a favourable prognostic factor in non-small-cell lung carcinoma
por: Hiraoka, K, et al.
Publicado: (2006)

Melanoma-expressed CD70 is involved in invasion and metastasis
por: Pich, Christine, et al.
Publicado: (2016)

Mesenchymal stem cells are enriched in head neck squamous cell carcinoma, correlates with tumour size and inhibit T-cell proliferation
por: Liotta, F, et al.
Publicado: (2015)

Tetraspanins CD9 and CD151, epidermal growth factor receptor and cyclooxygenase-2 expression predict malignant progression in oral epithelial dysplasia
por: Nankivell, P, et al.
Publicado: (2013)

Slice cultures from head and neck squamous cell carcinoma: a novel test system for drug susceptibility and mechanisms of resistance
por: Gerlach, M M, et al.
Publicado: (2014)

Analysis of exhaled breath for diagnosing head and neck squamous cell carcinoma: a feasibility study
por: Gruber, M, et al.
Publicado: (2014)

HPV infection in squamous cell carcinomas arising from different mucosal sites of the head and neck region. Is p16 immunohistochemistry a reliable surrogate marker?
por: Bussu, F, et al.
Publicado: (2013)

Tetraspanin CD151 is a novel prognostic marker in poor outcome endometrial cancer
por: Voss, M A, et al.
Publicado: (2011)

Co-expression of CD147 (EMMPRIN), CD44v3-10, MDR1 and monocarboxylate transporters is associated with prostate cancer drug resistance and progression
por: Hao, J, et al.
Publicado: (2010)

OPN/CD44v6 overexpression in laryngeal dysplasia and correlation with clinical outcome
por: Staibano, S, et al.
Publicado: (2007)

PDK-1 regulates lactate production in hypoxia and is associated with poor prognosis in head and neck squamous cancer
por: Wigfield, S M, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_n9i3515jed8ii73blghhu49cp3